![Stephen William Bunting](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen William Bunting
Directeur/Membre du Conseil chez
Abingworth Bioventures IV GP Ltd.
Profil
Stephen William Bunting is the founder of Hexagen Plc, Astex Therapeutics Ltd., deVGen NV.
He currently holds director positions at Abingworth Bioventures V GP Ltd., Abingworth Bioventures IV GP Ltd., Abingworth Ventures (GP) Ltd., Abingworth Trustee Ltd., Elkinbrook Ltd., and Abingworth Management Holdings Ltd. He formerly held various director positions at Aurora Biosciences Corp., Cantab Pharmaceuticals Plc, Akubio Ltd., Galapagos NV, Genetic Therapy, Inc., Galapagos Biotech Ltd., Ablynx NV, Abingworth Bioventures IIA GP Ltd., and Prosensa Holding NV.
He was also the Chairman of Abingworth LLP from 2011 to 2019 and the Managing Partner of Abingworth Management Ltd. He holds a doctorate degree from The University of Reading.
Postes actifs de Stephen William Bunting
| Sociétés | Poste | Début |
|---|---|---|
Abingworth Bioventures IV GP Ltd. | Directeur/Membre du Conseil | - |
Abingworth Bioventures V GP Ltd.
 Abingworth Bioventures V GP Ltd. Investment Trusts/Mutual FundsMiscellaneous Functions as an investment fund | Directeur/Membre du Conseil | - |
Abingworth Trustee Ltd. | Directeur/Membre du Conseil | - |
Abingworth Ventures (GP) Ltd. | Directeur/Membre du Conseil | - |
Elkinbrook Ltd. | Directeur/Membre du Conseil | - |
Abingworth Management Holdings Ltd.
 Abingworth Management Holdings Ltd. Investment ManagersFinance Engages in management of investment funds | Directeur/Membre du Conseil | - |
Anciens postes connus de Stephen William Bunting
| Sociétés | Poste | Fin |
|---|---|---|
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Private Equity Investor | 31/07/2019 |
| ABLYNX | Directeur/Membre du Conseil | 07/11/2013 |
Akubio Ltd.
 Akubio Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops acoustic biosensor instruments | Directeur/Membre du Conseil | 31/05/2010 |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Stephen William Bunting
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Health Technology |
Cantab Pharmaceuticals Plc
 Cantab Pharmaceuticals Plc MiscellaneousMiscellaneous Discovery and development of biopharmaceutical products based on advances in immunology | Miscellaneous |
Akubio Ltd.
Akubio Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops acoustic biosensor instruments | Electronic Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Abingworth Management Ltd.
 Abingworth Management Ltd. Investment ManagersFinance Operates as an investment firm | Finance |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
N.M. Rothschild & Sons Ltd.
 N.M. Rothschild & Sons Ltd. Major BanksFinance Provides banking and financial services | Finance |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human gene therapy delivery products | Commercial Services |
Hexagen Plc
 Hexagen Plc BiotechnologyHealth Technology Develops technology for discovery of single nucleotide polymorphisms | Health Technology |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services | Health Technology |
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Health Technology |
The University of Reading
 The University of Reading Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
deVGen NV
 deVGen NV BiotechnologyHealth Technology Provides biotechnology services for the pharmaceutical and agrochemical industries | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Abingworth Bioventures V GP Ltd.
Abingworth Bioventures V GP Ltd. Investment Trusts/Mutual FundsMiscellaneous Functions as an investment fund | Miscellaneous |
Abingworth Bioventures IV GP Ltd. | |
Abingworth Bioventures IIA GP Ltd.
 Abingworth Bioventures IIA GP Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Prosensa Holding NV
 Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders | Health Technology |
Abingworth Ventures (GP) Ltd. | |
Abingworth Trustee Ltd. | |
Elkinbrook Ltd. | |
Abingworth Management Holdings Ltd.
Abingworth Management Holdings Ltd. Investment ManagersFinance Engages in management of investment funds | Finance |
